Although cancer‐derived EVs have been shown to contain IL‐6 (Ramteke et al., 2015; Skog et al., 2009) the impact of EV‐delivered IL‐6 on cells within the tumour microenvironment has not been explored. The gene discussed is IL6; the disease is neoplasm.